{
    "code": "10000307",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000307",
    "time": "2020-02-26 01:35:54",
    "許可證字號": "衛署菌疫輸字第000307號",
    "註銷狀態": "已註銷",
    "註銷日期": "98\/12\/16",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "89\/03\/24",
    "發證日期": "79\/03\/24",
    "許可證種類": "菌　疫",
    "舊證字號": "10000108",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000030702",
    "中文品名": "人體乙型肝炎免疫球蛋白注射劑",
    "英文品名": "HEPATITIS B IMMUNE GLOBULIN (HUMAN) &quot;ABBOTT&quot;",
    "適應症": "預防Ｂ型肝炎之感染",
    "劑型": "270注射劑",
    "包裝": "小瓶 注射針筒",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "GAMMAGLOBULIN",
    "限制項目": "02輸　入",
    "申請商名稱": "1426701100  台灣亞培大藥廠股份有限公司",
    "申請商地址": "台北巿民生東路三段４９號六樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0005000  ABBOTT LAB. (ABBOTT PHARMACEUTICALS INC. DIV. OF ABBOTT LAB.)",
            "製造廠廠址": "ROCKY MOUNT, NORTH CAROLINA, 27802NORTH CHICAGO, ILLINOIS 60064",
            "製造廠公司地址": "NORTH CHICAGO, ILLINOIS 60064",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8004000500",
            "成分名稱": "GAMMAGLOBULIN",
            "含量描述": "165",
            "含量": "165.0000000000",
            "單位": "MG"
        }
    ]
}